As ERK1/2 is subject to a number of distinct mechanisms of regulation, further investigations in CD56dimCD16+ NK cells from CFS/ME patients are required to determine if these regulatory mechanisms contribute to reduce ERK1/2 phosphorylation. Here, MAPK3 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.